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DANIIL F. GLUZMAN 
(ON THE 80TH BIRTH ANNIVERSARY)
In June 2016, Professor Daniil Fishelevich Gluzman, well-known Ukrainian oncohematologist, celebrates his 80th anniversary.
D.F. Gl�zman grad�ated from Bogomolets Kyiv 
Medical Instit�te in �9�� and started his medical 
career as the pediatric physician in Ovr�ch Pediatric 
Hospital� Zhytomyr region. Since �9��� he started his 
research activity as the research fellow at the Instit�te 
of Experimental and Clinical Oncology �nowadays — 
R.E. Kavetsky Instit�te of Experimental Pathology� 
Oncology and Radiobiology of the National Aca­
demy of Sciences of Ukraine� — the Instit�te where 
he worked for many years �nder the s�pervision of its 
first director� the famo�s Ukrainian oncologist and 
pathophysiologist Academician R.E. Kavetsky� the 
Instit�te where Daniil Fishelevich was inspired from the 
first days by the creative atmosphere of scientific work� 
the Instit�te to which Daniil Fishelevich has been com­
mitted himself for life. His first research started at the 
Department of Le�kemogenesis Mechanisms headed 
by Academician Z.A. B�tenko� where Dr. D.F. Gl�zman 
�pheld his thesis for candidate’s degree in �9�7� and 
doctoral thesis in �975. And in �9��� D.F. Gl�zman� 
by then — Doctor of Medicine and Professor� headed 
the Laboratory of Cytochemistry and Imm�nocyto­
chemistry �nowadays — Department of Oncohemato­
logy� adhering to the ideas and traditions that were set 
forth by his famo�s teachers.
Prof. D.F. Gl�zman is well known by his pioneering 
research in developing the cytochemical methods for 
st�dying the progenitor cells in vario�s hematopoietic 
lineages. His pivotal st�dies on identification of the he­
matopoietic stem cells in the yolk sac have been widely 
recognized providing the basis for the advanced st�dy 
of the relationship between the malignant transforma­
tion in ontogenesis and the origin of le�kemias in the 
children. Prof. D.F. Gl�zman with his colleag�es has 
convincingly demonstrated that hematopoietic pro­
genitor cells believed morphologically �nidentifiable 
possess the marker cytochemical feat�res inherent 
to the mat�re cells of the specified hematopoietic lin­
eages. These data were in line with gro�nd­breaking 
research on stem cells initiated at o�r Instit�te as early 
as in 7�­s of XX cent�ry by the leaders of Ukrainian 
oncology science Academicians R.E. Kavetsky 
and Z.A. B�tenko. In partic�lar� the findings demon­
strated by Prof. D.F. Gl�zman represented the theo­
retical gro�nds for the �se of cytochemical methods 
in delineation of vario�s forms and cytological variants 
of ac�te le�kemias res�lting from the transformation 
and clonal proliferation of vario�s categories of hema­
topoietic progenitor cells. And in fact� the cytochemical 
st�dies of blood cells have been widely �sed in diffe­
rential diagnosis of vario�s forms of ac�te le�kemias 
appearing val�able for their classification. The res�lts 
of this research o�tlined in a series of the monographs 
“Diagnostic Cytochemistry of Hemoblastoses” ��97��; 
“Cytochemistry and Imm�nocytology of Malignant 
Lymphoproliferative Diseases” ��9���; “Embryonic 
Hemopoiesis and Hemoblastoses in Children” ��9��� 
are widely q�oted by those engaged in cytochemical 
st�dy of blood cells.
In the Department headed by D.F. Gl�zman� 
in ��­s of XX cent�ry the team of Dr. S.P. Sidorenko 
�now corresponding member of the National Academy 
of Sciences of Ukraine� and other yo�ng at that time 
research fellows being inspired by the hybridome 
technology boom prod�ced the first­ever monoclo­
nals in Ukraine against differentiation and activation 
antigens of the cells of h�man hematopoietic and 
lymphoid tiss�es. The novel imm�nocytochemical 
techniq�es for the detection of the wide array of the 
antigens in blast cells in the smears of blood and bone 
marrow� fine­needle p�nctates of lymph nodes and 
t�mors have been elaborated and improved allowing 
for high q�ality and precision of diagnostic examina­
tions based on imm�nophenotyping of le�kemic cells. 
The theoretical fo�ndations and general principles 
of applying cytochemical and imm�nocytochemical 
markers in the diagnosis of vario�s forms of le�ke­
mia and malignant lymphoma have been elaborated. 
F�rthermore� in a series of st�dies the role of lectin 
receptors differing in carbohydrate specificity in the 
mat�ration of hematopoietic cells of vario�s origins 
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has been el�cidated. The biotinylated neoglicoprotein 
probes were �sed in the original st�dies of endo­
geno�s lectins in normal and le�kemic hematopoietic 
and lymphoid cells.
The practical implementation of the complex 
of modified cytomorphological� cytochemical and 
imm�nocytochemical techniq�es has been advanta­
geo�s for improving the level of diagnosing the ma­
lignant t�mors of hematopoietic and lymphoid tiss�es 
in Ukraine to meet the req�irements of the �p­to­date 
classifications �sed in Western co�ntries. The inno­
vative theoretical developments of the Department 
headed by Prof. D.F. Gl�zman laid the gro�ndwork 
for the large­scale practical activities in diagnosing 
le�kemia and lymphoma among the patients referred 
by medical instit�tions from Kyiv and all over Ukraine. 
The extensive network connecting the Department 
of Imm�nocytochemistry �nowadays — Department 
of Oncohematology� and dozens of clinical facilities 
all over Ukraine proved to be the effective tool for 
assisting the clinicians­hematologists in diagnosing 
precisely vario�s hematological malignancies. Ann�­
ally� diagnostic tests �sing modern technologies are 
provided in more than �5�� patients from �� regions 
of Ukraine. Of partic�lar note is the assistance pro­
vided to the children with cancer pathology. The state­
of­the­arts in modern diagnosis of le�kemias as well 
as the long­term practical experience of the Depart­
ment headed by Prof. D.F. Gl�zman were s�mmarized 
in the series of monographs comprising “Imm�nocy­
tochemistry and Monoclonal Antibodies in Oncohe­
matology” ��99��� “Imm�nocytochemical Diagnosis 
of Malignant Sero�s Eff�sions” ��99��� “Laboratory 
Diagnosis of Oncohematological Diseases” ��99��� 
“Le�kemia Diagnosis. Atlas and Practical Handbook” 
������ becoming the g�idebooks for clinicians­
hematologists and the specialists in experimental and 
clinical oncohematology in Ukraine. Prof. D.F. Gl�zman 
was the first to develop and apply methods for iden­
tification of micrometastases and t�mor cells in bone 
marrow� lymph nodes� sero�s ex�dates and cerebro­
spinal fl�id by applying imm�nocytochemical tech­
niq�es and monoclonal antibodies against organ­ and 
tiss�e­specific� oncofetal� t�mor­associated antigens� 
cytoskeletal proteins. Act�ally� Prof. D.F. Gl�zman cre­
ated the �niq�e school of tho�ght for cytologists and 
oncohematologists in Ukraine.
In post­Chernobyl period� the Department of On­
cohematology headed by Prof. D.F. Gl�zman has been 
engaged in diagnostic examination of Ukrainian pa­
tients s�ffered from the conseq�ences of Chernobyl 
catastrophe with the partic�lar foc�s on diagnosing 
le�kemias in Chernobyl clean­�p workers and the 
children from the most affected regions. The res�lts 
of the long­term research by D.F. Gl�zman and his 
colleag�es have drawn the attention of scientific 
comm�nity to the real sit�ation with hematopoietic 
malignancies in relation to low doses of radiation. After 
Chernobyl� the Reference Laboratory of R.E. Kavetsky 
Instit�te has become an internationally known center. 
It is of high importance that s�ch research was s�p­
ported by the specialists in oncohematology from 
many co�ntries. In �99������� the st�dy of le�ke­
mias in clean­�p workers was performed within the 
framework of joint Ukrainian­�apanese gro�p on st�dy 
of le�kemia and lymphoma. This international labora­
tory performed the cytological and imm�nophenotypi­
cal st�dy of le�kemias in Chernobyl clean­�p workers 
and compared their forms and cytological variants 
to that occ�rred in Hiroshima and Nagasaki many years 
after the atomic bombing. These data were presented 
at the Radiation Effects Research Fo�ndation �RERF� 
�apan� in �999 and ���� and s�mmarized in a series 
of p�blications in international jo�rnals. For many 
years� D.F. Gl�zman collaborated as hematologist 
with French Center “Children of Chernobyl” providing 
expertise in diagnosing the hematological diseases 
among the children from the regions of Ukraine con­
taminated with radion�clides. Prof. D.F. Gl�zman was 
involved in the activity of the international committee 
of the experts­hematologists set �p for verification 
of the diagnoses of oncohematological pathologies 
within the framework of the collaborative research 
program sponsored by USA. Taking into acco�nt the 
high q�ality of diagnosing le�kemias in children� the 
Department headed by Prof. D.F. Gl�zman was se­
lected as the only team from Ukraine for the project 
“My Child Matters” sponsored by Sanofi­Aventis and 
International Union Against Cancer in ��������7. 
In the setting of this project� the large assistance was 
provided for the improvement of diagnosing cancer 
and le�kemia in the children of o�r co�ntry.
Prof. D.F. Gl�zman is a scientist of permanent cre­
ative endeavor. He p�t forward the novel approach for 
st�dying radiation­associated le�kemias� in partic�lar 
myelodysplastic syndromes and chronic lymphocytic 
le�kemia in post­Chernobyl setting. Recently� the 
findings on radiation­associated le�kemias have been 
s�mmarized in the collective monograph “Ionizing Ra­
diation and Oncohematological Diseases” ������ Aca­
demician V.F. Chekh�n and Professor D.F. Gl�zman� 
eds.� commemorating ��th anniversary of Chernobyl 
catastrophe. Based on the comprehensive analysis 
of malignantly transformed le�kemic cells� the novel 
approaches to classification of hemoblastoses and 
models of hematopoiesis are �nder way.
Prof. D.F. Gl�zman a�thored �� monographs and 
more than �5� scientific papers on vario�s aspects 
of oncology and hematology� made n�mero�s presen­
tations and reports aro�nd the world. He has s�pervised 
� doctoral and �5 Ph.D. theses. Prof. D.F. Gl�zman 
dedicates a lot of time to p�blishing activities. For 
many years Prof. D.F. Gl�zman is Associate Editor �now 
Chairman of the Editorial Board� of the international 
jo�rnal “Experimental Oncology” and Dep�ty Editor­in­
Chief of the jo�rnal “Oncology”. It may be said witho�t 
exaggeration that not only the iss�es of the jo�rnals 
b�t many other p�blications of o�r Instit�te have been 
edited thoro�ghly by s�ch a q�alified specialist as Daniil 
Fishelevich. Prof. D.F. Gl�zman is also member of the 
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Editorial Board of jo�rnals “Hematology and Transf�sio­
logy”� “Laboratory Diagnosis”� Member of Ukrainian 
Society of Hematologists� Ukrainian Society of Oncolo­
gists� Associate Member of the International Network 
of Cancer Treatment and Research �INCTR�.
Prof. D.F. Gl�zman combines his research activity 
with tremendo�s practical and organizational work 
aimed at organization of highly q�alified labora­
tory assistance in diagnosing patients in Ukraine 
with pathologies of hematopoietic system. A series 
of booklets entitled “Seminars in Hematopathology” 
��5 iss�es in total� initiated by Prof. D.F. Gl�zman and 
his colleag�es highlights the recent achievements and 
novelties in diagnosing oncohematological diseases. 
As a good tradition� the ann�al scientific­and­metho­
dological seminars on the �rgent problems of cyto­
chemistry and imm�nocytology of hemoblastoses 
organized by Department of Oncohematology gather 
dozens of specialists in hematology and laboratory. 
The recent monographs “Diagnostic Oncohemato­
logy” ������ and “Modern methods of laboratory 
diagnosis of oncohematological diseases” ������ give 
a big boost for the improvement of skills of Ukrainian 
specialists in hematology.
Prof. D.F. Gl�zman received many honors d�ring 
his long career. He is the Honored Master of Science 
and Technology of Ukraine. In ����� D.F. Gl�zman 
was among the first scientists awarded the memo­
rial R.E. Kavetsky Prize of the National Academy 
of Sciences of Ukraine for the series of scientific works 
“Novel approaches and technologies in diagnosis 
and treatment of cancer”. Recently� D.F. Gl�zman 
has been among the team awarded the State Prize 
of Ukraine in Science and Technology for the series 
of works “Monoclonal and recombinant antibodies for 
experimental biology� medicine and veterinary” ����5�.
The prominent professional skills of Daniil Fishe­
levich are accompanied by his o�tstanding personal 
traits. It is not too m�ch to say that he stim�lates and 
inspires the dozens of scientists who work with him 
over the years. We all appreciate his passion� his 
drive� and his willingness to stand �p and fight for 
what he believes.
The administration and the staff of R.E. Kavetsky 
Instit�te of Experimental Pathology� Oncology and 
Radiobiology of the National Academy of Sciences 
of Ukraine� Editorial Board� all his colleag�es have 
a great pleas�re to congrat�late Prof. D.F. Gl�zman 
on the occasion of his ��th birthday and to wish him 
good health� inexha�stible energy� long years of f�rther 
activity as a scientist and new scientific achievements.
Scientific Council and scientists 
of R.E. Kavetsky Institute of Experimental 
Pathology, Oncology and Radiobiology 
of the National Academy of Sciences of Ukraine
Editorial Boards of “Experimental Oncology” 
and “Oncology” journals
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